NCT03188458View on ClinicalTrials.gov

Immunogenicity of a Single Dose of GSK Biologicals' Boostrix™ in Infants Prior to Primary Pertussis Vaccination, When Administered to Pregnant Women as Per Routine Practice in Bogota, Colombia

PHASE4TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 29, 2018

Primary Completion Date

October 22, 2018

Study Completion Date

October 22, 2018

Conditions

Diphtheria-Tetanus-Acellular Pertussis

Interventions

OTHER

Blood sample

Blood samples will be collected from infants prior to their first routine primary pertussis vaccination (At Visit 2 \[approximately 4-8 weeks of age\]).

Trial Locations (1)

Unknown

GSK Investigational Site, Bogotá